You have open access to this content

Cancer Medicine

Cover image for Vol. 1 Issue 1

August 2012

Volume 1, Issue 1

Pages i–ii, 1–104

  1. Issue Information

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Cancer Biology
    5. Cancer Prevention
    6. Clinical Cancer Research
    1. You have full text access to this OnlineOpen article
      Issue Information (pages i–ii)

      Article first published online: 1 AUG 2012 | DOI: 10.1002/cam4.26

  2. Editorial

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Cancer Biology
    5. Cancer Prevention
    6. Clinical Cancer Research
    1. You have full text access to this OnlineOpen article
      Personalized medicine at a prime time for cancer medicine – Introducing Cancer Medicine (page 1)

      Qingyi Wei

      Article first published online: 2 APR 2012 | DOI: 10.1002/cam4.1

      Thumbnail image of graphical abstract

      We are entering an important era when cancer medicine is being transformed into personalized medicine. At this time, I am delighted to introduce Cancer Medicine, a new Wiley Open Access interdisciplinary journal, which is committed to rapidly disseminating cutting-edge research and will consider submissions from all oncologic specialties, including, but not limited to, the areas of cancer biology, clinical cancer research and cancer prevention to advance the personalized care of cancer patients.

    2. You have full text access to this OnlineOpen article
      Integrity at Cancer Medicine: the research we publish, how we evaluate it, and what we ask of our authors (pages 2–4)

      Chris Graf and David L. Vaux

      Article first published online: 17 JUL 2012 | DOI: 10.1002/cam4.8

      Thumbnail image of graphical abstract

      This Editorial describes how the Editors of Cancer Medicine will establish and maintain high standards of data integrity and publication ethics in all the papers published in the journal. We have set detailed guidelines for authors and reviewers and we will monitor compliance with those guidelines.

  3. Cancer Biology

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Cancer Biology
    5. Cancer Prevention
    6. Clinical Cancer Research
    1. Original Research

      You have full text access to this OnlineOpen article
      Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cells (pages 5–16)

      Fan Fan, Shaija Samuel, Kurt W. Evans, Jia Lu, Ling Xia, Yunfei Zhou, Eric Sceusi, Federico Tozzi, Xiang-Cang Ye, Sendurai A. Mani and Lee M. Ellis

      Article first published online: 8 JUN 2012 | DOI: 10.1002/cam4.4

      Thumbnail image of graphical abstract

      Novelty and impact of the paper

      We found that Snail, a transcription factor that mediates epithelial-to-mesenchymal transition (EMT), was overexpressed in human colorectal cancer (CRC) specimens. Snail overexpression in human CRC cells by retroviral infection led to an increase in the EMT and the cancer stem cell-like phenotype. In addition, Snail-mediated chemoresistance in CRC cells in vitro and metastasis in vivo. Snail is a potential therapeutic target in CRC and inhibition of Snail activity may serve as a novel method to enhance the efficacy of chemotherapy and improve outcomes of patients with metastatic CRC.

    2. You have full text access to this OnlineOpen article
      Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β (pages 17–27)

      Brenda L. Petrella and Matthew P. Vincenti

      Article first published online: 7 JUN 2012 | DOI: 10.1002/cam4.7

      Thumbnail image of graphical abstract

      Inflammation is a poor prognostic indicator for renal cell carcinoma (RCC), and metastatic RCC remains a major medical concern, as it is refractory to standard therapies. We hypothesized that inflammatory cytokines in the tumor microenvironment directly affect RCC tumor cells to progress to a metastatic phenotype. We report that IL-1β stimulated RCC tumor cell invasion in a mechanism that required the activation of the CCAAT Enhancer Binding Protein-β (CEBPβ) transcription factor and the subsequent induction of Matrix Metalloproteinases (MMPs).

    3. You have full text access to this OnlineOpen article
      ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells (pages 28–38)

      Byung-Kwon Choi, Xuejun Fan, Hui Deng, Ningyan Zhang and Zhiqiang An

      Article first published online: 15 JUL 2012 | DOI: 10.1002/cam4.10

      Thumbnail image of graphical abstract

      This study reports that an anti-HER2 antibody increased proliferation and migration of the low HER2 expressing MCF7 cancer cells by inducing HER3/EGFR dimerization independent of HER3 ligand stimulation. The results suggest that equilibrium of dimerization among the HER receptors can be perturbed by HER targeting antibodies and HER3 is a key sensor in the regulation of HER family receptor signaling.

    4. You have full text access to this OnlineOpen article
      Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS) (pages 39–46)

      Mikio Masuzawa, Mamiko Masuzawa, Yuhko Hamada, Nobuko Arakawa, Mari Mori, Masako Ishii and Shigeo Nishiyama

      Article first published online: 13 JUL 2012 | DOI: 10.1002/cam4.12

      Thumbnail image of graphical abstract

      The concept of “lymphangiosarcoma” remains obscure. Therefore, we reported a patient with lymphangiosarcoma, resistant to immunotherapy. From this case, a lymphangiosarcoma cell line, MO-LAS, was established and its characteristics were compared with the hemangiosarcoma cell line, ISO-HAS.

  4. Cancer Prevention

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Cancer Biology
    5. Cancer Prevention
    6. Clinical Cancer Research
    1. Original Research

      You have full text access to this OnlineOpen article
      Exposure to welding fumes increases lung cancer risk among light smokers but not among heavy smokers: evidence from two case–control studies in Montreal (pages 47–58)

      Eric Vallières, Javier Pintos, Jérôme Lavoué, Marie-Élise Parent, Bernard Rachet and Jack Siemiatycki

      Article first published online: 7 JUN 2012 | DOI: 10.1002/cam4.6

      Thumbnail image of graphical abstract

      Welding is one of the most ubiquitous of industrial activities, and consequently, welding fumes is one of the most common industrial exposures throughout the world. This paper contributes to the evidence that exposure to welding fumes may increase the risk of lung, most evidently among non-smokers and mild smokers. This holds true for the two major classes of welding, arc welding, and gas welding.

    2. You have full text access to this OnlineOpen article
      Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping (pages 59–67)

      Shichao Ge, Bo Gong, Xushan Cai, Xiaoer Yang, Xiaowei Gan, Xinghai Tong, Haichuan Li, Meijuan Zhu, Fengyun Yang, Hongrong Zhou and Guofan Hong

      Article first published online: 5 JUL 2012 | DOI: 10.1002/cam4.9

      Thumbnail image of graphical abstract

      The high-risk HC2 test correctly detected 388 (57.6%) of the 674 high-risk HPV isolates in clinical specimens, mislabeled 88 (46.8%) of the 188 low-risk HPV isolates as high-risk genotypes, and classified 180 (27.4%) of the 657 “true negative” samples as being infected by high-risk HPV. It was found to cross-react with 20 low-risk HPV genotypes. We conclude that nested PCR detection of HPV followed by short target DNA sequencing can be used for screening and genotyping to formulate a paradigm in clinical management of HPV-related disorders in a rapidly developing economy.

  5. Clinical Cancer Research

    1. Top of page
    2. Issue Information
    3. Editorial
    4. Cancer Biology
    5. Cancer Prevention
    6. Clinical Cancer Research
    1. Original Research

      You have full text access to this OnlineOpen article
      RET expression and detection of KIF5B/RET gene rearrangements in Japanese lung cancer (pages 68–75)

      Hidefumi Sasaki, Shigeki Shimizu, Yoichi Tani, Masahiko Maekawa, Katsuhiro Okuda, Keisuke Yokota, Masayuki Shitara, Yu Hikosaka, Satoru Moriyama, Motoki Yano and Yoshitaka Fujii

      Article first published online: 12 JUL 2012 | DOI: 10.1002/cam4.13

      Thumbnail image of graphical abstract

      Original FISH probes were used for KIF5B/RET translocation in lung adenocarcinimas.

    2. You have full text access to this OnlineOpen article
      CIP2A protein expression in high-grade, high-stage bladder cancer (pages 76–81)

      Lisa P. Huang, Diana Savoly, Abraham A. Sidi, Martin E. Adelson, Eli Mordechai and Jason P. Trama

      Article first published online: 15 JUL 2012 | DOI: 10.1002/cam4.15

      Thumbnail image of graphical abstract

      Our studies show that CIP2A protein is specifically expressed in human bladder tumor. CIP2A is preferentially expressed in high-grade and high-stage TCC tumor, which is high-risk and invasive tumor. CIP2A might be useful for the surveillance of bladder cancer progression

    3. You have full text access to this OnlineOpen article
      Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer (pages 82–88)

      Linda Marklund, Anders Näsman, Torbjörn Ramqvist, Tina Dalianis, Eva Munck-Wikland and Lalle Hammarstedt

      Article first published online: 3 JUN 2012 | DOI: 10.1002/cam4.2

      Thumbnail image of graphical abstract

      Low prevalence of HPV in oropharyngeal cancer outside the base of tongue and tonsills. No clear impact of HPV on outcome.

    4. You have full text access to this OnlineOpen article
      Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study (pages 89–95)

      Francesco Recchia, Giampiero Candeloro, Giovambattista Desideri, Stefano Necozione, Cornelia O. C. Recchia, Vincenzo Cirulli and Silvio Rea

      Article first published online: 31 MAY 2012 | DOI: 10.1002/cam4.3

      Thumbnail image of graphical abstract

      Multidisciplinary approach in triple negative breast cancer. High-dose chemotherapy. Platinum analogues.

    5. You have full text access to this OnlineOpen article
      Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer (pages 96–104)

      Azharuddin Sajid Syed Khaja, Lars Egevad, Leszek Helczynski, Peter Wiklund, Tommy Andersson and Anders Bjartell

      Article first published online: 4 JUN 2012 | DOI: 10.1002/cam4.5

      Thumbnail image of graphical abstract

      We have now been able to confirm our previous results, that Wnt5a can be used as a predictive biomarker in prostate cancer patients following radical prostatectomy. This finding may also be of importance from a therapeutic point of view as it indicates an opportunity to treat prostate cancer patients with low-grade tumors and positive surgical margin status after radical prostatectomy by targeting Wnt5a signaling. Subsequent therapeutical experiments are on-going.

SEARCH

SEARCH BY CITATION